Carcinogenesis, Teratogenesis & Mutagenesis ›› 2019, Vol. 31 ›› Issue (1): 9-14,21.doi: 10.3969/j.issn.1004-616x.2019.01.002

Previous Articles     Next Articles

Establishment and optimization of droplet microfluidic single-cell transcriptome detection technology

ZHOU Lulin1, YANG Runkun2, ZHANG Wen3, FENG Lin1, XIAO Ting1, CHENG Shujun1, ZHANG Kaitai1, ZHANG Lei4   

  1. 1. State Key Laboratory of Molecular Oncology, Beijing Key Laboratory for Carcinogenesis and Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021;
    2. Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086;
    3. Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021;
    4. Department of Endoscope, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2018-11-15 Revised:2018-12-29 Online:2019-01-31 Published:2019-01-31

Abstract: OBJECTIVE:To establish and to validate a droplet microfluidic single-cell transcriptome detection platform for cancer research. METHODS:Using a droplet microfluidic system,a single cell and a single barcoded microparticle were wrapped together in an oil-water emulsion droplet. The mixed human acute promyelocytic leukemia cell line HL-60 and the mouse melanoma cell line B16-F10 were used as simulative sample to evaluate the technical indexes of the system. RESULTS:When the oil and the water phase flow rates were 200 and 30 μL/min,respectively,and the cell and microparticle concentrations were at 250 and 400/μL,the optimum cell labeling rate was reached at (11.87±3.75)%. With a simulative sample which contained 75 thousand cells and the theoretical cell labeling rate of 11%,the transcriptome data of 7 535 cells was obtained,among which there were 70 mixed human and mouse transcriptome cells accounting for only 0.9% of all cells. Transcriptome differences were used to distinguish the two types of cells and to screen out the specific expression markers among them. CONLUSION:In this study,a droplet microfluidic single-cell transcriptome detection platform was initiated and validated. The platform meets the requirements of oncology laboratory and shows extensive potential for tumor research.

Key words: single-cell sequencing, microfluidic, transcriptome, tumor cells

CLC Number: